Mariagrazia Ruvoletto

Title: Mariagrazia Ruvoletto: Innovator in Medical Therapeutics

Introduction

Mariagrazia Ruvoletto is a prominent inventor based in Vigonovo, Italy. She has made significant contributions to the field of medicine through her innovative research and patents. Her work focuses on the therapeutic applications of extracellular vesicles, which have the potential to revolutionize treatment for various acute pathologies.

Latest Patents

Mariagrazia Ruvoletto holds a patent for "Extracellular vesicles isolated from genetically modified cells over-expressing SERPINB3 for use in medicine." This invention concerns the therapeutic use of extracellular vesicles isolated from a genetically modified cell line that over-expresses SerpinB3. The therapeutic applications are aimed at treating acute pathologies characterized by ischemic or inflammatory tissue damage, as well as cell injury due to oxidative stress. Examples of conditions that could benefit from this invention include cardiac, cerebral, intestinal, renal, or limb ischemia. Additionally, the invention addresses the preservation of transplant organs, such as the heart, lung, liver, bladder, pancreas, and intestine. Furthermore, it relates to a pharmaceutical composition comprising these extracellular vesicles and a pharmaceutically acceptable vehicle.

Career Highlights

Mariagrazia Ruvoletto is affiliated with the Università Degli Studi Di Padova, where she continues her research and development in the field of medical therapeutics. Her dedication to advancing medical science is evident in her innovative approach to addressing critical health issues.

Collaborations

Some of her notable coworkers include Alessandra Biasiolo and Gianmarco Villano. Their collaborative efforts contribute to the ongoing research and development in the field of extracellular vesicles and their therapeutic applications.

Conclusion

In summary, Mariagrazia Ruvoletto is an influential inventor whose work in the field of medical therapeutics has the potential to significantly impact the treatment of various acute pathologies. Her innovative patent highlights the importance of research in developing new therapeutic strategies.